TMCI · Treace Medical Concepts, Inc.
$4.00
-0.05 (-1.23%)
At close · Jul 24
Market Cap
$259.49M
Shares
64.87M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Treace | CEO | $5,405,190 |
| Mark L. Hair | CFO | $5,157,046 |
| Sean F. Scanlan | Chief Innovation Officer | $2,310,894 |
| Scot M. Elder | Chief Legal & Compliance Officer, Corporate Secretary | $2,123,983 |
| Gaetano M. Guglielmino | Chief Commercial Officer | $468,536 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John Treace | CEO | $6,597,160 |
| Scot M. Elder | Chief Legal & Compliance Officer, Corporate Secretary | $4,550,615 |
| Mark L. Hair | CFO | $4,485,302 |
| Gaetano M. Guglielmino | Chief Commercial Officer | $3,230,098 |
| Sean F. Scanlan | Chief Innovation Officer | $3,085,435 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John Treace | CEO | $8,422,635 |
| Mark L. Hair | CFO | $4,686,509 |
| Aaron J. Berutti | Senior Vice President, Sales | $3,262,358 |
| Scot M. Elder | Chief Legal & Compliance Officer, Corporate Secretary | $3,156,616 |
| Sean F. Scanlan | Chief Innovation Officer | $2,949,878 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John Treace | CEO | $3,617,249 |
| Mark L. Hair | CFO | $1,537,970 |
| Aaron J. Berutti | Senior Vice President, Sales | $1,428,785 |
| Sean F. Scanlan | Chief Innovation Officer | $1,338,182 |
| Scot M. Elder | Chief Legal & Compliance Officer, Corporate Secretary | $1,321,857 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Aaron J. Berutti | Senior Vice President, Sales | $1,931,173 |
| Mark L. Hair | CFO | $1,303,477 |
| John Treace | CEO | $688,145 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mark L. Hair | CFO | $1,414,871 |
| John Treace | CEO | $392,399 |